FindTrial
Sign In

Splenic Hilar Nodes in Splenic Flexure Cancer

Aberrant Lympahtic Drainage of Splenic Flexure Cancer: Are Splenic Hilar Nodes Metastases an Underecognized Phenomenon?

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04666883
Enrollment
20
Registered
2020-12-14
Start date
2021-01-01
Completion date
2021-03-01
Last updated
2020-12-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Colon Cancer, Metastases, Lymphatic

Brief summary

Report the incidence of metastases to the splenic hilar lymphnodes from splenic flexure primaries. This mode of spread has not been previously characterized for these tumours.

Interventions

OTHERReview of records and follow up

Follow up to identify patients who developed splenic hilar nodal metastases

Sponsors

University of Rome Tor Vergata
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* All splenic flexure cancer patients

Exclusion criteria

* No consent to data utilization

Design outcomes

Primary

MeasureTime frameDescription
Splenic hilum nodal metastases5 yearsSplenic hilum nodal metastases

Countries

Italy

Contacts

Primary ContactBruno Sensi, MD
brunosensi@outlook.it3385352902
Backup ContactGiuseppe S Sica, MD, PhD
sigisica@gmail.com3385333659

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026